301. Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method.
- Author
-
Zhang H, Liang B, Sang X, An J, and Huang Z
- Subjects
- Humans, SARS-CoV-2, Antiviral Agents pharmacology, Antiviral Agents chemistry, Pandemics, Artificial Intelligence, Protease Inhibitors pharmacology, Protease Inhibitors chemistry, Machine Learning, Molecular Docking Simulation, COVID-19
- Abstract
The COVID-19 pandemic caused by SARS-CoV-2 remains a global public health threat and has prompted the development of antiviral therapies. Artificial intelligence may be one of the strategies to facilitate drug development for emerging and re-emerging diseases. The main protease (M
pro ) of SARS-CoV-2 is an attractive drug target due to its essential role in the virus life cycle and high conservation among SARS-CoVs. In this study, we used a data augmentation method to boost transfer learning model performance in screening for potential inhibitors of SARS-CoV-2 Mpro . This method appeared to outperform graph convolution neural network, random forest and Chemprop on an external test set. The fine-tuned model was used to screen for a natural compound library and a de novo generated compound library. By combination with other in silico analysis methods, a total of 27 compounds were selected for experimental validation of anti-Mpro activities. Among all the selected hits, two compounds (gyssypol acetic acid and hyperoside) displayed inhibitory effects against Mpro with IC50 values of 67.6 μM and 235.8 μM, respectively. The results obtained in this study may suggest an effective strategy of discovering potential therapeutic leads for SARS-CoV-2 and other coronaviruses.- Published
- 2023
- Full Text
- View/download PDF